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Background: Previous heart rate variability (HRV) studies in asthmatic subjects (AS) demonstrate predominance of
parasympathetic drive concomitant with low HRV, which is against the general belief that enhanced parasympathetic
modulation improves HRV. The aim of this study was to compare patterns of HRV and cardiac autonomic modulations
of AS to healthy control subjects (HS).
Methods: Eighty AS and forty HS were enrolled in the study. Asthma control test and spirometry were used
to discriminate uncontrolled (UA) from controlled (CA) asthmatic patients. Natural logarithmic (Ln) scale of total power
(TP), very low frequency (VLF), low frequency (LF) and high frequency (HF) were used to evaluate HRV. Normalized
low frequency (LF Norm) and high frequency (HF Norm) were used to determine sympathetic and parasympathetic
autonomic modulations respectively.
Results: CA patients achieved significantly higher LnTP, LnLF, LnHF and HF Norm but lower LF Norm and LnLF/HF
compared with UA patients (p < 0.05). Although CA patients showed increased HRV and augmented vagal modulation
compared with HS, these findings were no longer significant following adjustment for mean heart rates and anti-asthma
treatment. All measured HRV parameters were not significantly different in UA patients compared with the HS (p > 0.05).
Conclusions: CA is associated with enhanced parasympathetic modulations and higher HRV compared with UA.
However, neither CA nor UA patients had different autonomic modulations and/or HRV compared with HS.
Keywords: Asthma control, Autonomic modulation, Heart rate variability
Background
Assessment of heart rate variability (HRV) is one of the
most popular methods used to evaluate autonomic mod-
ulations of the heart [1]. Recent research exploring
deranged autonomic functions in certain diseases was
largely based on HRV studies [2–4]. Bronchial asthma
has received special attention by researchers investigat-
ing the impact of autonomic disturbances on the disease
etiology [5–11]. Low HRV and predominance of para-
sympathetic modulations on the heart were demon-
strated in some studies [5–8], but not others [9–11].
According to some previous reports, parasympathetic
discharge seems to predominate in asthmatic patients
irrespective of day-and-night cycle [12] or physical activity
[5]. Conversely, some studies were unable to prove vagal
hypertonia in patients with bronchial asthma [6]. Based
on HRV derived indices, Gupta et al. failed to demonstrate
parasympathetic predominance in asthmatic patients;
however, their results suggested sympathetic withdrawal
among the studied patients [6]. Garcia-Araújo and
colleagues compared the autonomic modulation in 14
controlled asthmatic patients and 10 healthy volunteers at
rest and during exercise. Their results suggested that con-
trolled asthmatic patients had an increased sympathetic
modulation and attenuated response to the postural
changes [9]. In another study, HRV and cardiac autonomic
modulations in difficult-to-control asthma patients were
not different compared with healthy subjects [10].
In clinical practice, low HRV suggests increased
susceptibility to cardiac arrhythmias secondary to auto-
nomic imbalance [13, 14]. Enhanced parasympathetic
Correspondence: mohamedfaisallutfi@gmail.com
Department of Physiology, Faculty of Medicine and Health Sciences,
Al-Neelain University, Khartoum, Sudan
© 2015 Lutfi. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lutfi BMC Pulmonary Medicine  (2015) 15:119 
DOI 10.1186/s12890-015-0118-8
drive is expected to increase HRV. Nonetheless, most
studies in asthmatic patients that document shift of
sympathovagal balance towards predominance of para-
sympathetic drive also demonstrate reduced HRV [5–8].
These contradictory findings are difficult to explain
physiologically and may point to hidden confounders
[15–18]. From a physiological standpoint, exploring vari-
ations in HRV in asthmatic patients should consider
differences in heart rate [15, 16] and medical treatments
[18, 19] among these patients. Altered heart rate is
expected in asthmatic patients as a result of activation of
the chemoreceptor reflex triggered by hypoxia/hypercapnia;
sympathetic stimulation triggered by the stress of asthma
attack; and beta-2 agonist therapy. Alternatively, heart rate
is inversely proportional to beat-to-beat intervals, from
which all HRV parameters are derived. Consequently, re-
sults of studies that do not adjust for asthma-associated
changes in heart rates, and anti-asthma treatments (AAT),
while comparing HRV and autonomic modulations be-
tween asthmatic and non-asthmatic subjects are question-
able and deserve re-evaluation. Previous reports that failed
to show predominance of vagal drive in asthmatic individ-
uals may be biased by heterogeneous patterns of autonomic
modulations among asthmatic patients [9–11]. Poor re-
sponse of difficult-to-control asthma patients to anticholin-
ergic drugs raises the question of whether enhanced vagal
drive contributes to the pathogenesis of asthma in
these patients [19, 20]. A negative answer is suggested
by a recent study, which fails to demonstrate significant
difference in the autonomic modulations between difficult-
to-control asthma patients and healthy control subjects
[10]. Further studies are required to verify if parasympa-
thetic drive predominates in all asthmatic patients regard-
less of their disease control, AAT and asthma-associated
changes in heart rates. The aim of this study was to com-
pare patterns of HRV and cardiac autonomic modulations
of asthmatic patients to healthy control subjects, taking
into consideration possible influences of degree of asthma
control, AAT and asthma-associated changes in heart
rates on HRV.
Methods
The study received ethical clearance from the ethics
review committee at the Faculty of Medicine, University
of Khartoum, Sudan. All volunteers provided informed
written consent before being involved in the study.
Eighty (41 males and 39 females) known asthmatic
subjects (AS) with no past medical history of other
chronic pulmonary diseases were matched for age, gen-
der, weight and height with a control group of 40 (22
males and 18 females) apparently healthy subjects (HS).
All studied individuals were young adults, and had
no past medical history of smoking, diabetes mellitus,
hypertension, heart disease or other diseases that
may affect cardiac autonomic modulations. The test
group was recruited from respiratory referral clinics of the
Khartoum teaching hospitals, Sudan. The control subjects
were students and doctors of the Faculty of Medicine and
Health Sciences, Al-Neelain University, Khartoum, Sudan.
Following evaluation of past medical history, including
intensity of anti-asthma treatment offered to the pa-
tients, all volunteers underwent clinical examination and
investigations during the period from 09.00 AM–12.00
PM to avoid confounding effects of circadian rhythm on
asthma severity, spirometry and HRV. Using asthma con-
trol test (ACT), a score of 15 or less was used to discrim-
inate uncontrolled (UA) from controlled asthmatic (CA)
patients [21, 22]. For further verification of ACT, venti-
latory function was evaluated in each class using spir-
ometry. For the purpose of adjustment for anti-asthma
medications, patients were further categorized into: off-
treatment patients, patients on beta-2 agonists only and
patients on combined beta-2 agonists and steroids. A
GIMA scale (GIMA S.p.A, Milan, Italy) was used to meas-
ure weight and height. Body mass index (BMI) was de-
termined by the formula: BMI (kg/m2) = weight/height
squared. Spirometry and HRV were performed ac-
cording to the standard methods using Allflow Spirom-
eter (Version 5.18, Clement Clarke International Limited,
Harlow, UK) and Biocom 3000 ECG recorder (Heart
Rhythm Scanner, Version 2.0, Biocom Technologies,
Poulsbo, WA, U.S.A) respectively [15, 23].
HRV parameters were derived from 5-min electrocar-
diogram (ECG) recordings in the supine position after
ensuring clean ECG signals, absence of movement arti-
facts and comfortable breathing. Frequency domain ana-
lysis was used to determine HRV and cardiac autonomic
modulations in the different groups. Natural logarithm
(Ln) of total power (LnTP), very low frequency (LnVLF),
low frequency (LnLF) and high frequency (LnHF) were
used to evaluate HRV. Alternatively normalized low fre-
quency (LF Norm) and high frequency (HF Norm) were
used to determine sympathetic and parasympathetic auto-
nomic modulations respectively [24]. The Biocom 3000
ECG recorder also calculated the mean heart rate (MHR)
at the time of ECG recording.
Statistical analysis
Statistical analysis was done using SPSS for windows
(Version 16; Chicago, IL, USA). Variables were described
by means, median, standard deviations (SD), 25 quartile
(Q1) and 75 quartile (Q3) based on their distribution
curves. Using appropriate statistical tests, comparable
distributions of gender, ages and BMI among control
and test groups were established. Concordance of spiro-
metric measurements with ACT groups was ensured to
approve proper grading of asthma severity by ACT.
Means (SD) and median (Q1-Q3) of frequency domain
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HRV parameters and spirometric measurements were
compared in the studied groups using one-way ANOVA
(Student’s T test for comparison between two groups)
and Kruskal–Wallis (Mann–Whitney U test for com-
parison between two groups) tests, respectively. Using a
general linear model MHR, and AAT for each subject
were introduced as covariates while comparing each HRV
parameter in the different studied groups. A value of
P < 0.05 was considered significant.
Results
Of the AS (n = 80), 37 [46.3; 95 % confidence interval
(CI): 35.8, 57.1 %] had CA and 43 (53.7; 95 % CI: 42.9,
64.3 %) had UA. The distribution of gender (chi2 = 0.15,
p = 0.698), ages, and BMI were comparable in AS and
HS. In contrast, MHR was significantly lower in HS
[83.6 (11.3) beats/min] compared with CA [90.3 (10.6)
beats/min, p = 0.012] and UA [88.6 (12.3) beats/min, p =
0.048] (Fig. 1). As shown in Table 1, all measured spiro-
metric indices were significantly increased in HS com-
pared with CA and UA. Except for peak expiratory flow
rate, the same spirometric measurements were signifi-
cantly increased in CA compared with UA.
CA patients achieved significantly higher LnTP, LnLF,
LnHF and HF Norm [7.40 (1.27) ms2/Hz, 6.23 (1.30)
ms2/Hz, 6.41 (1.65) ms2/Hz and 54.4 (16.4) normalized
unit (nu) respectively] compared with the HS [6.68
(1.31) ms, p = 0.023; 5.50 (1.43), p = 0.026; 5.32 (1.76)
ms, p = 0.008 and 45.9 (17.3) nu, p = 0.026 respectively]
as well as UA patients [median 6.64 (1.49) ms, p = 0.015;
5.53 (1.47) ms, p = 0.030; 5.31 (1.84) ms, p = 0.006 and
45.8 (17.6) nu, p = 0.026 respectively] (Table 2).
LF Norm and LnLF/HF were significantly lower in CA
patients [45.6 (16.4) nu and −0.19 (0.75) respectively]
compared with the HS [54.1 (17.3) nu, p = 0.021 and
0.19 (0.76), p = 0.040 respectively] as well as UA patients
[54.2 (17.6) nu, p = 0.041 and 0.22 (0.86), p = 0.022
respectively]. All measured frequency domain HRV pa-
rameters were not significantly different in UA patients
compared with HS (Table 2).
All HRV differences between the groups were still
significant following adjustment for MHR at the time of
HRV recording, except for LF Norm, HF Norm and
LnLF/HF, which became comparable in HS and CA pa-
tients (Table 2). Adjustment for MHR and AAT nullified
all significant variations between HS and CA but all
other differences between CA and UA patients remained
statistically significant (Table 2).
Discussion
It is evident from the present results that global HRV
and autonomic modulations of CA patients are signifi-
cantly different from UA patients irrespective of the pos-
sible influences of MHR and AAT on HRV. Based on
absolute and normalized HRV parameters, CA patients
had higher global HRV and augmented parasympathetic
autonomic modulations compared with UA patients.
Comparing HS to AS, it is clear that global HRV and
autonomic modulations of UA patients were comparable
to the HS group regardless of influences of MHR and
AAT on HRV. Although CA patients showed higher
HRV and augmented vagal modulation compared with
HS, these findings were no longer significant following
adjustment for MHR and AAT.
Several previous reports confirm predominance of the
parasympathetic nervous system on cardiac autonomic
modulations of asthmatic patients [5, 6, 25–27]. Gupta
et al. compared findings of spectral analysis HRV of 30
asthmatic patients aged 20–30 years to a similar number
of healthy volunteers. Their results confirmed lower LF
Fig. 1 Distribution of age, BMI (a) and MHR (b) among studied groups. * Significant compared with CA, # significant compared with UA
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Norm in asthmatic patients compared with the healthy
volunteers but failed to demonstrate significant differ-
ence in HF Norm among the studied groups [6]. These
findings were further supported by the work of Gomes
et al. who failed to demonstrate significant decrease in
HF power following shuttle walk tests offered to asth-
matic children. From an autonomic standpoint, the
Gomes et al. findings suggested predominance of para-
sympathetic cardiac modulations even during exercise,
when sympathetic effects were expected to dominate [5].
In another study, circadian rhythm of parasympathetic
nervous function disappeared in 9 out of the 80 asth-
matic children examined by Kazuma et al. but was
observed in all healthy children [12]. Absence of para-
sympathetic circadian rhythm in some asthmatic chil-
dren is probably due to persistent high parasympathetic
discharge. Interestingly, enhanced parasympathetic car-
diac modulations were proven in patients who are at
higher risk to develop asthma, e.g., those with allergic
rhinitis [28] and atopic dermatitis [29].
It is worth mentioning that the results of this study
stand midway between the findings of previous re-
searchers exploring autonomic modulations in asthmatic
patients. This is because the present results suggested
augmented parasympathetic and depressed sympathetic
autonomic modulations in CA compared with UA pa-
tients but fail to demonstrate similar differences in
autonomic trends when the AS group was compared
with HS. To our knowledge, the present study is the first
report to state clearly different patterns of cardiac auto-
nomic modulations among controlled and uncontrolled
asthmatic patients, although some previous reports gave
cues that may support the present hypothesis [10, 11].
Cabiddu et al. studied HRV in eight patients suffering
from difficult-to-control asthma during different stages
of sleep [10]. In healthy subjects in this study, HRV
showed predominant parasympathetic drive during non-
rapid eye movement sleep and an increased sympathetic
activity during rapid eye movement sleep. Spectral
analysis of HRV in difficult-to-control asthma patients
showed trends in the main spectral indices comparable
to the control subjects [10].
According to the present results, CA patients have
higher global HRV compared with UA subjects but the
HRV of either asthma group was comparable to HS.
Conversely, previous reports repeatedly demonstrated
reduced HRV among asthmatic patients compared with
healthy individuals [7, 9, 12, 30]. The incongruity of our
results with previous reports might be explained by the
unique design of our study which considered adjustment
for MHR and AAT while comparing AS to HS. Alterna-
tively, higher global HRV of CA compared with UA sub-
jects could be explained by the findings of a recent study
designed by Domnik et al. to assess the impact of
Table 1 ACT score and spirometric measurements among studied groups
HS CA UA P
N = 40 N = 37 N = 43
Mean (SD) Mean (SD) Mean (SD)
Median (Q1 –Q3) Median (Q1 –Q3) Median (Q1 –Q3)
ACT score 19.0 (17.0 – 21.0) 13.0 (10.0–13.0) <0.001*
FEV1% 90.5 (5.5) 78.5 (14.6) 68.0 (13.6) HS vs. CA < 0.001*
HS vs. UA < 0.001*
CA vs.UA < 0.001*
PEFR (L/sec) 7.4 (1.6) 5.3 (1.9) 4.5 (1.9) HS vs. CA < 0.001*
HS vs. UA < 0.001*
CA vs.UA = 0.054
FEF25% (L/sec) 6.8 (1.5) 4.7 (2.0) 3.5 (1.8) HS vs. CA < 0.001*
HS vs. UA < 0.001*
CA vs.UA = 0.006*
FEF50% (L/sec) 4.9 (3.7–6.1) 2.8 (2.0 – 4.4.0) 1.7 (1.0–2.6) HS vs. CA < 0.001*
HS vs. UA < 0.001*
CA vs.UA = 0.004*
FEF75% (L/sec) 2.3 (1.8–2.5) 1.2 (0.7 – 1.8) 0.7 (0.4–1.3) HS vs. CA < 0.001*
HS vs. UA < 0.001*
CA vs.UA = 0.005*
ACT Asthma control test, CA Controlled asthmatic, FEF Forced expiratory flow, FEV1 Forced expiratory volume in the first second, HS Healthy subjects, PEFR Peak
expiratory flow rate, Q1 25 quartile, Q3 75 quartile, SD Standard deviation, UA Uncontrolled asthma, * Statistically significant.
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allergic sensitization to ovalbumin on HRV in a murine
model [11]. The researchers were able to demonstrate
that sensitized mice had decreased HRV prior to ovalbu-
min challenge, increased HRV during antigen challenge
and finally decreased HRV subsequent to the challenge.
Based on these results, HRV is likely to increase in con-
trolled asthmatic patients who usually suffer from acute
intermittent exacerbations but not uncontrolled patients,
who usually suffer from persistent attacks. This conclu-
sion may explain why TP, LF and HF powers were higher
in CA patients examined in this study compared with
the UA subjects. Another salient point in this context is
that enhanced parasympathetic cardiac autonomic mod-
ulations are known to improve, rather than to weaken,
HRV [13, 14]. It appears logical that augmented para-
sympathetic cardiac autonomic modulations in CA asth-
matic patients will improve global HRV, as proved by
our results, and not depress HRV, as demonstrated by
previous studies.
The difference in the patterns of autonomic modula-
tions between CA and UA patients suggests synonymous
variation in the pathophysiological processes involved in
each group. In CA patients, enhanced parasympathetic
and attenuated sympathetic activity will aggravate bronch-
oconstriction of the respiratory tree and consequently
worsen airways narrowing. According to the present
results, parasympathetic autonomic discharge in UA pa-
tients is less than CA and comparable to HS suggesting
that other mechanisms are involved in inducing airways
obstruction in UA patients. Previous reports suggested
that UA patients are difficult to treat because they express
unique pathological myofilaments in bronchiolar smooth
muscles [31, 32] beside other airway changes [33, 34]. In
addition, the variations in the pattern of autonomic modu-
lations among asthmatic patients explain differences in
the response of asthma to conventional drugs that act on
the autonomic nervous system, e.g. UA patients may
respond badly to parasympatholytic drugs [19, 20].
Although it is widely accepted that the HF power is a
reliable indicator of parasympathetic modulations, the
validity of the LF power as a measure of sympathetic
modulations is a more contentious issue [35]. There is
growing evidence that the absolute values of LF are de-
termined by baroreflexes and therefore may efficiently
Table 2 Comparison of HRV parameters between groups
HS CA UA P values
N = 40 N = 37 N = 43 Non-Adjusted Adjusted for MHR Adjusted for MHR and AAT
Mean (SD) Mean (SD) Mean (SD)
LnTP (ms2/Hz) 6.68 (1.31) 7.40 (1.27) 6.64 (1.49) HS vs. CA = 0.023* HS vs. CA = 0.037* HS vs. CA = 0.673
HS vs. UA = 0.885 HS vs. UA = 0.857 HS vs. UA = 0.314
CA vs.UA = 0.015* CA vs.UA = 0.019* CA vs.UA = 0.020*
LnVLF (ms2/Hz) 5.47 (1.12) 5.87 (1.02) 5.36 (1.47) HS vs. CA = 0.157 HS vs. CA = 0.163 HS vs. CA = 0.821
HS vs. UA = 0.673 HS vs. UA = 0.950 HS vs. UA = 0.481
CA vs.UA = 0.065 CA vs.UA = 0.076 CA vs.UA = 0.080
LnLF (ms2/Hz) 5.50 (1.43) 6.23 (1.30) 5.53 (1.47) HS vs. CA = 0.026* HS vs. CA = 0.042* HS vs. CA = 0.658
HS vs. UA = 0.911 HS vs. UA = 0.668 HS vs. UA = 0.141
CA vs.UA = 0.030* CA vs.UA = 0.033 CA vs.UA = 0.031*
LnHF (ms2/Hz) 5.32 (1.76) 6.41 (1.65) 5.31 (1.84) HS vs. CA = 0.008* HS vs. CA = 0.016* HS vs. CA = 0.490
HS vs. UA = 0.979 HS vs. UA = 0.761 HS vs. UA = 0.346
CA vs.UA = 0.006* CA vs.UA = 0.007* CA vs.UA = 0.008*
LF Norm (nu) 54.1 (17.3) 45.6 (16.4) 54.2 (17.6) HS vs. CA =0.021* HS vs. CA =0.053 HS vs. CA =0.406
HS vs. UA =0.748 HS vs. UA =0.896 HS vs. UA =0.716
CA vs.UA =0.041* CA vs.UA =0.025 CA vs.UA =0.030*
HF Norm (nu) 45.9 (17.3) 54.4 (16.4) 45.8 (17.6) HS vs. CA =0.031* HS vs. CA =0.053 HS vs. CA =0.406
HS vs. UA =0.983 HS vs. UA =0.896 HS vs. UA =0.716
CA vs.UA =0.026* CA vs.UA =0.025* CA vs.UA =0.030*
LnLF/HF 0.19 (0.76) −0.19 (0.75) 0.22 (0.86) HS vs. CA = 0.040* HS vs. CA = 0.054 HS vs. CA = 0.438
HS vs. UA = 0.838 HS vs. UA = 0.983 HS vs. UA = 0.558
CA vs.UA = 0.022* CA vs.UA = 0.025* CA vs.UA = 0.029*
AAT Anti-asthma treatments, CA Controlled asthmatic, HF High frequency, HF Norm normalized high frequency, HRV Heart rate variability, HS Healthy subjects,
LF Low frequency, LF Norm normalized low frequency, Ln Natural logarithm, MHR Mean heart rate, SD Standard deviation, TP Total power, UA Uncontrolled asthma,
VLF Very low frequency, * Statistically significant.
Lutfi BMC Pulmonary Medicine  (2015) 15:119 Page 5 of 7
reflect parasympathetic tone [36]. The interpretation of
the present results was partly based on the normalized
LF and HF which, in contrast to their absolute values,
are inversely proportional and therefore may better re-
flect sympathetic and parasympathetic modulations [24].
Another limitation of this study is that respiratory rates
were not acknowledged in different study groups while
comparing their HRV. HRV is modulated by breathing
and evaluation of the rate of respiration in future studies
could offer better understanding for autonomic balance
in asthmatic patients.
Conclusions
The present results confirmed that degree of asthma con-
trol influences pattern of autonomic modulations/HRV
among AS. Enhanced parasympathetic modulations of-
fered higher HRV to CA compared with UA patients who
suffered from attenuated vagal tone. However, neither CA
nor UA patients were shown to have different autonomic
modulations and/or HRV compared with HS. The com-
parable autonomic modulations/HRV among AS and HS,
although different to several previous reports, were based
on a well-designed comparison that considered possible
influences of MHR and AAT on HRV.
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